仁和药业(000650) - 2023 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2023 was CNY 1,355,800,163.83, an increase of 3.39% compared to CNY 1,311,390,192.42 in the same period last year[6] - Net profit attributable to shareholders was CNY 182,299,215.54, representing a growth of 17.09% from CNY 155,695,612.25 year-on-year[6] - The net profit after deducting non-recurring gains and losses was CNY 175,174,269.85, up 23.34% from CNY 142,021,663.72 in the previous year[6] - Basic earnings per share increased to CNY 0.1302, up 17.09% from CNY 0.1112 year-on-year[6] - Operating profit for the first quarter was CNY 296,051,840.96, compared to CNY 257,635,696.12 in the previous year, reflecting an increase of about 14.9%[28] - Net profit attributable to the parent company was CNY 182,299,215.54, up from CNY 155,695,612.25 year-over-year, indicating a growth of approximately 17.1%[28] Cash Flow - The net cash flow from operating activities was -CNY 145,786,103.21, a decline of 48.06% compared to -CNY 98,462,253.02 in the same period last year[6] - Cash inflow from operating activities totaled 1,129,611,784.19 yuan, up from 1,069,263,178.46 yuan in Q1 2022, indicating a growth of about 5.6%[32] - Cash outflow from operating activities was 1,275,397,887.40 yuan, compared to 1,167,725,431.48 yuan in the previous year, reflecting an increase of approximately 9.2%[32] - Cash inflow from investment activities was 1,273,240,473.57 yuan, down from 1,452,261,905.90 yuan in Q1 2022, a decrease of about 12.3%[35] - Cash outflow from investment activities increased to 2,924,946,861.05 yuan from 2,425,428,238.45 yuan, marking a rise of approximately 20.6%[35] - Net cash flow from investment activities was -1,651,706,387.48 yuan, compared to -973,166,332.55 yuan in the same quarter last year, indicating a significant decline[35] - The ending balance of cash and cash equivalents was 1,027,984,204.90 yuan, down from 1,288,794,795.96 yuan year-over-year, a decrease of about 20.2%[35] Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,674,834,465.36, a slight increase of 0.57% from CNY 7,631,643,912.76 at the end of the previous year[6] - Total liabilities decreased from CNY 1,209,855,727.22 to CNY 1,033,752,161.57, a reduction of approximately 14.6%[25] - The company's cash and cash equivalents decreased from CNY 2,825,476,695.59 at the beginning of the year to CNY 1,027,984,204.90 at the end of the reporting period[19] - The total current assets decreased from CNY 4,580,859,200.27 to CNY 4,503,672,685.49[19] - The company's other non-current financial assets increased from CNY 536,405,208.66 to CNY 621,323,838.80[19] Shareholder Information - Shareholders' equity attributable to the parent company was CNY 5,923,088,209.67, reflecting a growth of 3.18% from CNY 5,740,788,994.13 at the end of last year[6] - Total number of common shareholders at the end of the reporting period was 154,479[15] - The company has a notable shareholder concentration, with the top shareholder holding 23.24% of the shares[15] - The total number of preferred shareholders at the end of the reporting period was not specified, but the top 10 shareholders' details were provided[19] Research and Development - Research and development expenses decreased by 45.47% to CNY 7,684,761.30 from CNY 14,092,315.49 in the same period last year[11] - Research and development expenses for the quarter were CNY 7,684,761.30, down from CNY 14,092,315.49, a decrease of about 45.5%[26] Accounts Receivable and Inventory - The company reported a significant increase in receivables, with accounts receivable rising by 70.94% to CNY 595,350,415.36 from CNY 348,270,958.86 year-on-year[11] - Accounts receivable rose from CNY 348,270,958.86 to CNY 595,350,415.36, indicating a growth of approximately 70.9%[19] - Inventory decreased slightly from CNY 457,735,527.05 to CNY 443,724,549.60[19] Tax and Other Expenses - The company reported a tax expense of CNY 75,847,801.25, compared to CNY 62,942,981.47 in the previous year, an increase of approximately 20.5%[28] Other Information - The company reported a cash inflow from sales of goods and services of 1,102,861,186.52 yuan, compared to 1,049,759,062.30 yuan in the previous year, an increase of approximately 5.1%[32] - The company did not report any significant new product launches or market expansions during this quarter[36]